USA - engelsk - NLM (National Library of Medicine)

bayer healthcare pharmaceuticals inc. - riociguat (unii: ru3fe2y4xi) (riociguat - unii:ru3fe2y4xi) - riociguat .5 mg - adempas is indicated for the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (cteph), (who group 4) after surgical treatment, or inoperable cteph, to improve exercise capacity and who functional class [see clinical studies (14.1)]. adempas is indicated for the treatment of adults with pulmonary arterial hypertension (pah), (who group 1), to improve exercise capacity, who functional class and to delay clinical worsening. efficacy was shown in patients on adempas monotherapy or in combination with endothelin receptor antagonists or prostanoids. studies establishing effectiveness included predominately patients with who functional class ii–iii and etiologies of idiopathic or heritable pah (61%) or pah associated with connective tissue diseases (25%) [see clinical studies (14.2)] . based on data from animal reproduction studies, adempas may cause fetal harm when administered to a pregnant woman and is contraindicated in females who are pregnant. adempas was consistently

USA - engelsk - NLM (National Library of Medicine)

bayer healthcare pharmaceuticals inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 250 mg - cipro is indicated in adult patients for treatment of skin and skin structure infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, proteus vulgaris, providencia stuartii, morganella morganii, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus aureus, methicillin-susceptible staphylococcus epidermidis, or streptococcus pyogenes. cipro is indicated in adult patients for treatment of bone and joint infections caused by enterobacter cloacae, serratia marcescens, or pseudomonas aeruginosa. cipro is indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by escherichia coli, pseudomonas aeruginosa, proteus mirabilis, klebsiella pneumoniae, or bacteroides fragilis. cipro is indicated in adult patients for treatment of infectious diarrhea caused by escherichia coli (enterotoxigenic isolates), campylobacter jejuni, shigella boydii † , shigella dysenteri

USA - engelsk - NLM (National Library of Medicine)

bayer healthcare llc animal health division - pradofloxacin (unii: 6o0t5e048i) (pradofloxacin - unii:6o0t5e048i) - pradofloxacin 25 mg in 1 ml - veraflox is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of pasteurella multocida, streptococcus canis, staphylococcus aureus, staphylococcus felis, and staphylococcus pseudintermedius. do not use in dogs. pradofloxacin has been shown to cause bone marrow suppression in dogs. dogs may be particularly sensitive to this effect, potentially resulting in severe thrombocytopenia and neutropenia. quinolone-class drugs have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. pradofloxacin is contraindicated in cats with a known hypersensitivity to quinolones.

USA - engelsk - NLM (National Library of Medicine)

bayer healthcare llc animal health division - imidacloprid (unii: 3bn7m937v8) (imidacloprid - unii:3bn7m937v8), moxidectin (unii: ngu5h31yo9) (moxidectin - unii:ngu5h31yo9) - imidacloprid 100 mg in 1 ml - advantage multi for cats is indicated for the prevention of heartworm disease caused by dirofilaria immitis . advantage multi for cats kills adult fleas (ctenocephalides felis ) and is indicated for the treatment of flea infestations. advantage multi for cats is also indicated for the treatment and control of ear mite (otodectes cynotis ) infestations and the following intestinal parasites: intestinal parasite intestinal stage adult immature adult fourth stage larvae hookworm species ancylostoma tubaeforme x x x roundworm species toxocara cati x x for ferrets: advantage multi for cats is indicated for the prevention of heartworm disease in ferrets caused by dirofilaria immitis . advantage multi for cats kills adult fleas (ctenocephalides felis ) and is indicated for the treatment of flea infestations on ferrets.

USA - engelsk - NLM (National Library of Medicine)

bayer healthcare llc animal health division - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457), emodepside (unii: yz647y5gc9) (emodepside - unii:yz647y5gc9) - praziquantel 30 mg in 0.35 ml - profender topical solution is indicated for the treatment and control of hookworm infections caused by ancylostoma tubaeforme (adults, immature adults, and fourth stage larvae), roundworm infections caused by toxocara cati (adults and fourth stage larvae), and tapeworm infections caused by dipylidium caninum (adults) and taenia taeniaeformis (adults) in cats.

USA - engelsk - NLM (National Library of Medicine)

bayer healthcare, llc animal health division - moxidectin (unii: ngu5h31yo9) (moxidectin - unii:ngu5h31yo9) - coraxis is indicated for the prevention of heartworm disease caused by dirofilaria immitis. coraxis is also indicated for the treatment and control of the following intestinal parasites: intestinal parasite intestinal stage adult immature adult fourth stage larvae hookworm species ancylostoma caninum x x x uncinaria stenocephala x x x roundworm species toxocara canis x x toxascaris leonina x whipworm trichuris vulpis x do not administer this product orally. (see warnings.) do not use this product (containing 2.5% moxidectin) on cats.

Singapore - engelsk - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - antihemophilic factor (recombinant) sucrose formulated - injection, powder, lyophilized, for solution - 1000 iu/vial - antihemophilic factor (recombinant) sucrose formulated 1000 iu/vial

Singapore - engelsk - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - antihemophilic factor (recombinant) sucrose formulated - injection, powder, lyophilized, for solution - 250iu/vial - antihemophilic factor (recombinant) sucrose formulated 250iu/vial

Singapore - engelsk - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - antihemophilic factor (recombinant) sucrose formulated - injection, powder, lyophilized, for solution - 500iu/vial - antihemophilic factor (recombinant) sucrose formulated 500iu/vial

Singapore - engelsk - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - acetylsalicylic acid - tablet - 500 mg - acetylsalicylic acid 500 mg